Roschier‘s life sciences and health care offering adeptly handles a range of patent litigations and private equity transactions within the sector. Erik Ficks heads the group, where he has experience in regulatory matters and public procurement- he is also often engaged by pharma companies for these mandates. Björn Johansson Heigis works alongside him and is a key contact within the group for information technology-related matters, including MedTech.
Legal 500 Editorial commentary

Testimonials

Collated independently by Legal 500 research team.

  • ‘The team is very skilled, and are able to help the customer, according to their needs and strategy.’
  • ‘Their ability to understand our needs, and execute that diligently, to deliver the value we want to achieve.’

Key clients

  • Neurim Pharmaceuticals
  • Philip Morris International

Work highlights

Representing Neurim Pharmaceuticals in a multi-jurisdictional pharma patent case.
Representing KKR and RWK BidCo in their SEK 11.6 billion public offer for Biotage AB (publ).
Representing Investor AB on the acquisition by Advanced Instruments of Nova Biomedical for USD 2.2 billion.
Practice head

Erik Ficks

Other key lawyers

Björn Johansson Heigis